Zkusit zdarma
Relay Therapeutics, Inc.

Relay Therapeutics, Inc.

RLAY
Cena:
$ 13.53
-0.13 (-0.95%)
Valuace
85
Růst
38
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Is Relay Therapeutics a Buy After Promising Trial Results?

Is Relay Therapeutics a Buy After Promising Trial Results?

17:30 22-05-2026

Relay had its initial public offering in 2020. The company's lead therapy is being tested for the tr...

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

20:21 20-05-2026

CAMBRIDGE, Mass. , May 20, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clini...

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

20:21 20-05-2026

CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinic...

Why Relay Therapeutics Stock Popped on Wednesday

Why Relay Therapeutics Stock Popped on Wednesday

19:01 20-05-2026

This was aided by a pair of bullish analyst updates. The two pundits raised their price targets and ...

Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise

Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise

4:50 20-05-2026

Relay Therapeutics is undervalued as the market overlooks its potential to build a multi-indication ...

Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies Transcript

Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies Transcript

23:10 19-05-2026

Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalie...

Relay Therapeutics Announces Proposed Public Offering of Common Stock

Relay Therapeutics Announces Proposed Public Offering of Common Stock

16:03 19-05-2026

CAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinic...

Relay's treatment shown to shrink vascular malformations in mid-stage trial

Relay's treatment shown to shrink vascular malformations in mid-stage trial

6:02 19-05-2026

Relay Therapeutics said on Tuesday a mid-stage trial showed its experimental treatment can shrink va...

Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates

Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates

19:10 05-05-2026

Relay Therapeutics, Inc. (RLAY) came out with a quarterly loss of $0.41 per share versus the Zacks C...

Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates

Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates

16:05 05-05-2026

FDA Breakthrough Therapy designation granted to  zovegalisib for PIK3CA-mutant, HR+/HER2- advanced ...

Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026

Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026

16:05 29-04-2026

CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clin...

Relay Therapeutics, Inc. (RLAY) Discusses Zovegalisib Triplet Data and First-Line Breast Cancer Strategy Transcript

Relay Therapeutics, Inc. (RLAY) Discusses Zovegalisib Triplet Data and First-Line Breast Cancer Strategy Transcript

16:21 27-04-2026

Relay Therapeutics, Inc. (RLAY) Discusses Zovegalisib Triplet Data and First-Line Breast Cancer Stra...

JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. $RLAY

JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. $RLAY

5:03 07-04-2026

JPMorgan Chase and Co. cut its holdings in shares of Relay Therapeutics, Inc. (NASDAQ: RLAY) by 89.3...

Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

10:15 06-04-2026

Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The la...

SG Americas Securities LLC Acquires 189,004 Shares of Relay Therapeutics, Inc. $RLAY

SG Americas Securities LLC Acquires 189,004 Shares of Relay Therapeutics, Inc. $RLAY

5:01 06-04-2026

SG Americas Securities LLC increased its holdings in shares of Relay Therapeutics, Inc. (NASDAQ: RLA...

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Recommendation of “Moderate Buy” from Analysts

2:38 06-04-2026

Shares of Relay Therapeutics, Inc. (NASDAQ: RLAY - Get Free Report) have earned a consensus rating o...

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

16:05 02-04-2026

CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clin...

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.

15:03 19-03-2026

Nextech Invest increased its stake in Relay Therapeutics by 855,097 shares; the estimated trade valu...

Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?

Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?

11:01 16-03-2026

The data revealed on Monday that the 400mg BID fed regimen of zovegalisib demonstrated a median prog...

Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026

Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026

7:00 16-03-2026

400mg BID fed is the dose used in the ongoing Phase 3 ReDiscover-2 trial, which initiated mid-2025 1...

close

RELAY THERAPEUTICS TO PARTICIPATE IN GUGGENHEIM EMERGING OUTLOOK: BIOTECH SUMMIT 2026

04-02-2026
CAMBRIDGE, MASS., FEB. 04, 2026 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS ANNOUNCES ZOVEGALISIB GRANTED BREAKTHROUGH THERAPY DESIGNATION BY U.S. FDA FOR PIK3CA-MUTANT, HR+/HER2- ADVANCED BREAST CANCER

03-02-2026
DESIGNATION SUPPORTED BY ROBUST CLINICAL  DATA FROM REDISCOVER TRIAL WITH 600MG BID FASTED AND 400M...
Více zde

RELAY THERAPEUTICS ANNOUNCES EFFICACY SUBSET ANALYSIS OF ZOVEGALISIB (RLY-2608) + FULVESTRANT IN BREAST CANCER PATIENTS PRE-TREATED WITH SERD OR WITH ESR1 MUTATIONS AT SABCS 2025

12-12-2025
EFFICACY DATA REMAIN CONSISTENT WITH PREVIOUS DISCLOSURES, SHOWING 10.3-MONTH MEDIAN PFS IN ALL PATI...
Více zde

RELAY THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATES

06-11-2025
CONTINUED FOCUSED EXECUTION OF RLY-2608 CLINICAL TRIALS IN PI3KΑ-MUTATED  BREAST CANCER AND VASCUL...
Více zde

RELAY THERAPEUTICS TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES IN NOVEMBER

03-11-2025
CAMBRIDGE, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS ON NOVEMBER 6, 2025

30-10-2025
CAMBRIDGE, MASS., OCT. 30, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES IN SEPTEMBER

28-08-2025
CAMBRIDGE, MASS., AUG. 28, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATES

07-08-2025
PRESENTED UPDATED DATA AT ASCO SHOWING CONSISTENCY WITH PRIOR DATA, INCLUDING 10.3-MONTH MEDIAN PFS ...
Více zde

RELAY THERAPEUTICS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS ON AUGUST 7, 2025

31-07-2025
CAMBRIDGE, MASS., JULY 31, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS APPOINTS CLAIRE MAZUMDAR, PH.D., TO BOARD OF DIRECTORS

11-06-2025
CAMBRIDGE, MASS., JUNE 11, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS ANNOUNCES UPDATED DATA FOR RLY-2608 + FULVESTRANT FURTHER DEMONSTRATING CLINICALLY MEANINGFUL PROGRESSION FREE SURVIVAL AT ASCO 2025

02-06-2025
UPDATED INTERIM DATA REMAIN CONSISTENT, SHOWING 10.3-MONTH MEDIAN PFS OVERALL AND 11.0-MONTH MEDIAN ...
Více zde

RELAY THERAPEUTICS TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES IN JUNE

29-05-2025
CAMBRIDGE, MASS., MAY 29, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINIC...
Více zde

RELAY THERAPEUTICS TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES

08-05-2025
CAMBRIDGE, MASS., MAY 08, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINIC...
Více zde

RELAY THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATES

05-05-2025
CASH RUNWAY EXTENDED INTO 2029 INITIATION OF PHASE 3 REDISCOVER-2 TRIAL ON TRACK FOR MID-2025 INITIA...
Více zde

RELAY THERAPEUTICS TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS ON MAY 5, 2025

28-04-2025
CAMBRIDGE, MASS., APRIL 28, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLIN...
Více zde

RELAY THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CORPORATE UPDATES

26-02-2025
INITIATION OF PHASE 3 REDISCOVER-2 TRIAL OF RLY-2608 + FULVESTRANT ANTICIPATED IN THE MIDDLE OF 2025...
Více zde

RELAY THERAPEUTICS TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES

24-02-2025
CAMBRIDGE, MASS., FEB. 24, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS ON FEBRUARY 26, 2025

19-02-2025
CAMBRIDGE, MASS., FEB. 19, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2025
CAMBRIDGE, MASS., JAN. 07, 2025 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS ANNOUNCES UPDATED INTERIM DATA FOR RLY-2608 + FULVESTRANT DEMONSTRATING CONTINUED MATURATION OF CLINICALLY MEANINGFUL PROGRESSION FREE SURVIVAL

11-12-2024
NEW INTERIM DATA SHOW 11.4-MONTH MEDIAN PFS IN 2L PATIENTS WITH PI3KΑ-MUTATED, HR+/HER2- METASTATIC...
Více zde

RELAY THERAPEUTICS TO PRESENT UPDATED CLINICAL DATA ON RLY-2608 IN HR+/HER2- BREAST CANCER AT 2024 SAN ANTONIO BREAST CANCER SYMPOSIUM

09-12-2024
COMPANY TO HOST CONFERENCE CALL ON WEDNESDAY, DECEMBER 11, 2024 AT 7AM ET COMPANY TO HOST CONFERENCE...
Více zde

ELEVAR THERAPEUTICS AND RELAY THERAPEUTICS ANNOUNCE EXCLUSIVE GLOBAL LICENSING AGREEMENT FOR LIRAFUGRATINIB IN FGFR2-DRIVEN CHOLANGIOCARCINOMA AND OTHER SOLID TUMORS

03-12-2024
GLOBAL LICENSING AGREEMENT GRANTS ELEVAR THERAPEUTICS WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE ...
Více zde

RELAY THERAPEUTICS AND ELEVAR THERAPEUTICS ANNOUNCE EXCLUSIVE GLOBAL LICENSING AGREEMENT FOR LIRAFUGRATINIB IN FGFR2-DRIVEN CHOLANGIOCARCINOMA AND OTHER SOLID TUMORS

03-12-2024
GLOBAL LICENSING AGREEMENT GRANTS ELEVAR THERAPEUTICS WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE ...
Více zde

RELAY THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

06-11-2024
REPORTED INTERIM RLY-2608 DATA DEMONSTRATING 9.2-MONTH MEDIAN PFS IN HEAVILY PRE-TREATED PATIENTS WI...
Více zde

RELAY THERAPEUTICS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS ON NOVEMBER 6, 2024

30-10-2024
CAMBRIDGE, MASS., OCT. 30, 2024 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLINI...
Více zde

RELAY THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

10-09-2024
CAMBRIDGE, MASS., SEPT. 10, 2024 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLIN...
Více zde

RELAY THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

09-09-2024
CAMBRIDGE, MASS., SEPT. 09, 2024 (GLOBE NEWSWIRE) -- RELAY THERAPEUTICS, INC. (NASDAQ: RLAY), A CLIN...
Více zde

RELAY THERAPEUTICS ANNOUNCES POSITIVE INTERIM DATA FOR RLY-2608 DEMONSTRATING CLINICALLY MEANINGFUL PROGRESSION FREE SURVIVAL

09-09-2024
9.2-MONTH MEDIAN PFS IN HEAVILY PRE-TREATED PATIENTS WITH PI3KΑ-MUTATED, HR+/HER2- METASTATIC BREAS...
Více zde

RELAY THERAPEUTICS ANNOUNCES WEBCAST TO REPORT RLY-2608 DATA ON SEPTEMBER 9, 2024

06-09-2024
INTERIM DATA TO BE REPORTED FOR RLY-2608 600MG BID + FULVESTRANT IN 2L+, CDK4/6-EXPERIENCED PATIENTS...
Více zde

RELAY THERAPEUTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

06-08-2024
ANNOUNCED 3 NEW PROGRAMS, INCLUDING GENETIC DISEASE PROGRAMS IN VASCULAR MALFORMATIONS, FABRY DISEAS...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-03 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-11 01:00:008-KStáhnout
2025-06-11 00:00:008-KStáhnout
2025-06-06 01:00:008-KStáhnout
2025-06-06 00:00:008-KStáhnout
2025-06-04 01:00:008-KStáhnout
2025-06-04 00:00:008-KStáhnout
2025-05-05 01:00:008-KStáhnout
2025-05-05 01:00:0010-QStáhnout
2025-05-05 00:00:008-KStáhnout
2025-05-05 00:00:0010-QStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-26 00:00:0010-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-02-25 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-11 00:00:008-KStáhnout
2024-12-10 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-09-11 01:00:008-KStáhnout
2024-09-11 00:00:008-KStáhnout
2024-09-09 01:00:008-KStáhnout
2024-09-09 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-07-16 01:00:008-KStáhnout
2024-07-16 00:00:008-KStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-06-03 01:00:008-KStáhnout
2024-06-03 00:00:008-KStáhnout
2024-05-02 01:00:008-KStáhnout
2024-05-02 01:00:0010-QStáhnout
2024-05-02 00:00:008-KStáhnout
2024-05-02 00:00:0010-QStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-22 00:00:0010-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-21 23:00:0010-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-12 01:00:008-KStáhnout
2023-10-12 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-05-31 01:00:008-KStáhnout
2023-05-31 00:00:008-KStáhnout
2023-05-25 01:00:008-KStáhnout
2023-05-25 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-18 01:00:008-KStáhnout
2023-04-18 00:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-09-15 01:00:008-KStáhnout
2022-09-15 00:00:008-KStáhnout
2022-09-12 01:00:008-KStáhnout
2022-09-12 00:00:008-KStáhnout
2022-09-08 01:00:008-KStáhnout
2022-09-08 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-07-27 01:00:008-KStáhnout
2022-07-27 00:00:008-KStáhnout
2022-06-27 01:00:008-KStáhnout
2022-06-27 00:00:008-KStáhnout
2022-05-27 01:00:008-KStáhnout
2022-05-27 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-09 00:00:008-KStáhnout
2021-12-08 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-10-14 01:00:008-KStáhnout
2021-10-14 00:00:008-KStáhnout
2021-10-08 01:00:008-KStáhnout
2021-10-08 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-05-27 01:00:008-KStáhnout
2021-05-27 00:00:008-KStáhnout
2021-05-19 01:00:008-KStáhnout
2021-05-19 00:00:008-KStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-04-16 01:00:008-KStáhnout
2021-04-16 00:00:008-KStáhnout
2021-03-25 00:00:008-KStáhnout
2021-03-25 00:00:0010-KStáhnout
2021-03-24 23:00:008-KStáhnout
2021-03-24 23:00:0010-KStáhnout
2020-12-14 00:00:008-KStáhnout
2020-12-13 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-08-27 01:00:008-KStáhnout
2020-08-27 01:00:0010-QStáhnout
2020-08-27 00:00:008-KStáhnout
2020-08-27 00:00:0010-QStáhnout
2020-07-21 01:00:008-KStáhnout
2020-07-21 00:00:008-KStáhnout
preloader